On the 13th June 2024, the Force Foundation (Fondation Force pour l’innovation et la recherche en santé) has awarded the 2024 Trophees to a selection of innovative health projects. The ITM is proud to stand amongst the laureate, with project NizaPrev, led by Dr Emilie Crouchet and Dr Catherine Schuster.
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. Despite numerous efforts, curative treatment strategies remain unsatisfactory, and the risk of recurrence after surgery remains very high. NizaPrev “Biomarker-guided chemoprevention of liver cancer with nizatidine”, aims to accelerate the repositioning of nizatidine, a type 2 histamine receptor inhibitor, for the prevention of HCC by identifying and characterising new non-invasive biomarkers for monitoring treatment and stratifying patients at risk.
Find the publication on Fondation Force’s website here.